Cell biological factors associated with the response of breast cancer to systemic treatment
- 30 April 1993
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 19, 45-63
- https://doi.org/10.1016/0305-7372(93)90007-e
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.Journal of Clinical Oncology, 1993
- Clinical breast cancer, new developments in selection and endocrine treatment of patientsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast CancerNew England Journal of Medicine, 1992
- pS2 expression in primary breast carcinomas: Relationship to clinical and histological features and survivalBreast Cancer Research and Treatment, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine responseBritish Journal of Cancer, 1991
- Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), Insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Endocrine Treatment of Breast Cancer in WomenEndocrine Reviews, 1990
- Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapyBritish Journal of Cancer, 1990
- The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancerCancer, 1988